Overview
- Description
"Faron Pharmaceuticals Oy is a clinical-stage biopharmaceutical company developing novel treatments for medical conditions with unmet needs. Faron is focused on tackling cancers via novel immunotherapies utilizing the Company’s lead asset bexmarilimab, a novel anti-Clever-1 humanized antibody to reprogram myeloid cells (e.g. tumor associated macrophages (TAM) and myeloid leukemia cells). "
- Website
- Press Release
- Country
- Finland
- Sector
- Health Biotechnology